IP Verse

Aera patent opposition analysis

The comprehensive analysis of Aera opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Aera

Stay updated with the latest patent oppositions filed by Aera

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4298025
Sleeve-Shaped Outer Part, Combination Packaging Container Equipped Therewith, And Method For Separating The Combination Packaging ContainerGREINER PACKAGING AGJan 22, 2026FAERCH
EP4265536
Sleeve-Shaped Outer Part, Combination Packaging Container Equipped Therewith, And Method For Separating The Combination Packaging ContainerGREINER PACKAGING AGNov 25, 2025FAERCH
EP3943466
A Filler Compound And Use Of A Filler CompoundSAINT-GOBAIN PLACONov 19, 2025FLUGGER GROUP
EP4037666
Improvements To Devices And Methods For Delivery Of Substances To AnimalsRUMINANT BIOTECH CORP LIMITEDJan 31, 2025WRAYS SOLUTIONS
EP3335707
Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUPJan 17, 2025AERA
EP3934624
Topical Composition And Methods Of Measuring The Cooling Abaility Of A Topical CompositionFUTURA MEDICAL DEVELOPMENTS LIMITEDDec 9, 2024AERA
EP3977993
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZER INC.Oct 29, 2024QUIMICA SINTETICA
EP2395968
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM INTERNATIONAL GMBHOct 16, 2024AERA
EP2493466
Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMAAug 30, 2024ACCORD HEALTHCARE SLU
EP3765024
Novel Pharmaceutical Formulation Comprising Dual Nk-1/Nk-3 Receptor AntagonistsKANDY THERAPEUTICS LIMITEDAug 5, 2024AERA

Top clients of Aera

Top companies who are the clients of Aera

CompanyTotal
AERA18
GN HEARING8
GN HEARING OTICON7
GN HEARING WIDEX OTICON5
KS HIMPP3
FAERCH3
UDDEHOLMS3
ACCORD HEALTHCARE2
GALDERMA HOLDING2
INSUD PHARMA SL2